Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer PatientsZhe Yang, Caicun Zhou, Nong Yang et al.|Clinical Cancer Research|2018Cited by 551
Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinibXiaofei Wang, Ji Ming Wang, Jae‐Hong Kim et al.|Oncotarget|2017Cited by 16